BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 14695841)

  • 41. Synthesis and biological evaluation of pyrimidine analogs of antimycobacterial purines.
    Read ML; Braendvang M; Miranda PO; Gundersen LL
    Bioorg Med Chem; 2010 Jun; 18(11):3885-97. PubMed ID: 20488716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and antimycobacterial evaluation of novel 5,6-dimethoxy-1-oxo-2,5-dihydro-1H-2-indenyl-5,4-substituted phenyl methanone analogues.
    Ali MA; Samy JG; Manogaran E; Sellappan V; Hasan MZ; Ahsan MJ; Pandian S; ShaharYar M
    Bioorg Med Chem Lett; 2009 Dec; 19(24):7000-2. PubMed ID: 19879757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and anticonvulsant activity of N-benzylpyrrolo[2,3-d]-, -pyrazolo[3,4-d]-, and -triazolo[4,5-d]pyrimidines: imidazole ring-modified analogues of 9-(2-fluorobenzyl)-6-(methylamino)-9H-purine.
    Kelley JL; Davis RG; McLean EW; Glen RC; Soroko FE; Cooper BR
    J Med Chem; 1995 Sep; 38(19):3884-8. PubMed ID: 7562920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
    Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
    Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
    Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
    Wang A; Lv K; Li L; Liu H; Tao Z; Wang B; Liu M; Ma C; Ma X; Han B; Wang A; Lu Y
    Eur J Med Chem; 2019 Sep; 178():715-725. PubMed ID: 31229874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds.
    Moraski GC; Markley LD; Chang M; Cho S; Franzblau SG; Hwang CH; Boshoff H; Miller MJ
    Bioorg Med Chem; 2012 Apr; 20(7):2214-20. PubMed ID: 22391032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimycobacterial activity of diphenylpyraline derivatives.
    Weis R; Faist J; di Vora U; Schweiger K; Brandner B; Kungl AJ; Seebacher W
    Eur J Med Chem; 2008 Apr; 43(4):872-9. PubMed ID: 17714832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives.
    Trivedi A; Vaghasiya S; Dholariya B; Dodiya D; Shah V
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):893-9. PubMed ID: 21054238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 2-Chloro-6-(2-furyl)-9-(4-methoxybenzyl)-9H-purine.
    Braendvang M; Gundersen LL
    Acta Crystallogr C; 2007 May; 63(Pt 5):o274-6. PubMed ID: 17478910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imidazo[4,5-b]pyridine derivatives of potential tuberculostatic activity. Part 1: Synthesis and quantitative structure-activity relationships.
    Bukowski L; Kaliszan R
    Arch Pharm (Weinheim); 1991 Feb; 324(2):121-7. PubMed ID: 1906702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and biological evaluation of 2,6-disubstituted-9H-purine, 2,4-disubstitued-thieno[3,2-d]pyrimidine and -7H-pyrrolo[2,3-d]pyrimidine analogues as novel CHK1 inhibitors.
    Tian C; Han Z; Li Y; Wang M; Yang J; Wang X; Zhang Z; Liu J
    Eur J Med Chem; 2018 May; 151():836-848. PubMed ID: 29684894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and structure-activity relationships of novel substituted 8-amino, 8-thio, and 1,8-pyrazole congeners of antitubercular rifamycin S and rifampin.
    Jin Y; Gill SK; Kirchhoff PD; Wan B; Franzblau SG; Garcia GA; Showalter HD
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6094-9. PubMed ID: 21903392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization.
    Soares de Melo C; Feng TS; van der Westhuyzen R; Gessner RK; Street LJ; Morgans GL; Warner DF; Moosa A; Naran K; Lawrence N; Boshoff HI; Barry CE; Harris CJ; Gordon R; Chibale K
    Bioorg Med Chem; 2015 Nov; 23(22):7240-50. PubMed ID: 26522089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective anti-tubercular purines: synthesis and chemotherapeutic properties of 6-aryl- and 6-heteroaryl-9-benzylpurines.
    Braendvang M; Gundersen LL
    Bioorg Med Chem; 2005 Dec; 13(23):6360-73. PubMed ID: 16081292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimycobacterial activity of 1-substituted indolizines.
    Gundersen LL; Negussie AH; Rise F; ØStby OB
    Arch Pharm (Weinheim); 2003 Jun; 336(3):191-5. PubMed ID: 12822185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and antituberculosis activity of novel 5-styryl-4-(hetero)aryl-pyrimidines via combination of the Pd-catalyzed Suzuki cross-coupling and S(N)(H) reactions.
    Kravchenko MA; Verbitskiy EV; Medvinskiy ID; Rusinov GL; Charushin VN
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3118-20. PubMed ID: 24856062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pyrazolo[1,5-a]pyridine-3-carboxamide hybrids: Design, synthesis and evaluation of anti-tubercular activity.
    Lu X; Tang J; Cui S; Wan B; Franzblauc SG; Zhang T; Zhang X; Ding K
    Eur J Med Chem; 2017 Jan; 125():41-48. PubMed ID: 27654393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of novel isothiazolopyridines and their in vitro evaluation against Mycobacterium and Propionibacterium acnes.
    Malinka W; Swiątek P; Sliwińska M; Szponar B; Gamian A; Karczmarzyk Z; Fruziński A
    Bioorg Med Chem; 2013 Sep; 21(17):5282-91. PubMed ID: 23850103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and structure-activity relationships of novel fused ring analogues of Q203 as antitubercular agents.
    Kang S; Kim YM; Jeon H; Park S; Seo MJ; Lee S; Park D; Nam J; Lee S; Nam K; Kim S; Kim J
    Eur J Med Chem; 2017 Aug; 136():420-427. PubMed ID: 28527405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.